Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists

Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists

US Patent 9226931 · Granted Jan 5, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Stabilized oxymetazoline formulations and their uses2025
Methods of diagnosing and treating dry eye syndrome and compositions for treatin2025
Composition for treating ocular hyperemia and a method for treating ocular hyper2024
Methods of diagnosing and treating dry eye syndrome and compositions for treatin2024
Two-factor authentication based on computation method to derive proxy password2024
Methods of diagnosing and treating dry eye syndrome and compositions for treatin2023
Stabilized oxymetazoline formulations and their uses2022
Topical composition for treating rosacea and a method for treating rosacea with 2021
High viscosity macromolecular compositions for treating ocular conditions2021
Dermal filler2020
Stabilized oxymetazoline formulations and their uses2020
Sustained release bimatoprost, bimatoprost analogs, prostamides and prostaglandi2020